Charles C. Guo
The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Bladder and Urothelial Cancer Treatments, Urinary and Genital Oncology Studies, Peptidase Inhibition and Analysis, Cancer Immunotherapy and Biomarkers, Testicular diseases and treatments
Most-Cited Works
- → Bladder cancer(2016)1,431 cited
- WHO Classification of of Tumours of the Urinary System and Male Genital Organs(2016)
- → Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance(2006)356 cited
- → Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use(2016)337 cited
- → Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma(2020)305 cited
- → The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer(2020)265 cited
- → Renal Epithelioid Angiomyolipoma With Atypia: A Series of 40 Cases With Emphasis on Clinicopathologic Prognostic Indicators of Malignancy(2010)251 cited
- → What Is the Significance of Variant Histology in Urothelial Carcinoma?(2019)238 cited
- → SALL4 Is a Novel Diagnostic Marker for Testicular Germ Cell Tumors(2009)234 cited
- → MIR-210 modulates mitochondrial respiration in placenta with preeclampsia(2012)229 cited